CN1252289A - Medicine for rheumarthritis and rheumatoid arthritis and its preparation - Google Patents
Medicine for rheumarthritis and rheumatoid arthritis and its preparation Download PDFInfo
- Publication number
- CN1252289A CN1252289A CN 98120481 CN98120481A CN1252289A CN 1252289 A CN1252289 A CN 1252289A CN 98120481 CN98120481 CN 98120481 CN 98120481 A CN98120481 A CN 98120481A CN 1252289 A CN1252289 A CN 1252289A
- Authority
- CN
- China
- Prior art keywords
- medicine
- rheumatoid arthritis
- diclofenac
- preparation
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The medicine is a compound Chinese-Western medicine and is compounded with Diclofenac, marasmius androsaceus spantol, Tabellae Gavipini, safflower, Resina Draconis, Radix Clematidis, Herba Lycopodii and pangolin scales in a certain proportion. The Chinese and Western medicines are treated separately based on their different properties and then compounded. The medicine may be prepared into various dosage forms, such as capsule. The present invention has unique recipe and preparation process and the medicine can relieve the root cause and symtoms at the same time with high curative effect.
Description
The present invention relates to a kind of medicine for the treatment of rheumatism and rheumatoid arthritis, specifically a kind of is the treatment rheumatism made of raw material and the medicament of rheumatoid arthritis with Chinese herbal medicine and part Western medicine, the invention still further relates to the preparation method of this medicine.
Rheumatism and rheumatoid arthritis are the high common diseases of a kind of sickness rate, and the misery of bringing for patient's body and mind is very big, the physical and mental health that is seriously endangering the people.Medical circles adopt various plaster treatments of external application or Western medicine for oral administration for this type of disease more at present, though the local disease symptom of energy respite is difficult to reach radical cure, and dredging the meridian is not had good effect, and the life-time service Western medicine easily causes drug dependence, and side effect is very big.
The object of the present invention is to provide a kind of medicine for the treatment of rheumatism and rheumatoid arthritis, not only can eliminate its various symptoms quickly, and can make the erythrocyte sedimentation rate value recover normal range, patient's whole body is played the effect of dredging the meridian, reach the effect of effecting a permanent cure.Instant effect, curative effect height, toxic and side effects are low, and are difficult for recurrence.
Another object of the present invention provides the preparation method of this rheumatism and treating rheumatoid arthritis agent.
Solution of the present invention is based on the understanding of motherland's medical science to the mechanism of rheumatism and rheumatoid arthritis, filters out the natural drug of blood circulation promoting and blood stasis dispelling, removing obstruction in the collateral to relieve pain from motherland's medicine treasure-house, and in conjunction with modern medicine, selects for use part Western medicine prescription to form compound preparation.Each medicine synergism of distinguishing the flavor of is to reach curative effect.
Medicine of the present invention is made by following component: (consumption is a weight portion)
Diclofenac 3-10 marasmius androsaceus 0.5-1 spaleston 0.15-0.4
Gavirin tablet 0.03-0.07 Flos Carthami 4-8 Sanguis Draxonis 5-10
Radix Clematidis 3-8 Herba Lycopodii 3-7 system Squama Manis 7-15
Formula optimization weight (part) ratio range of preparation medicine of the present invention is:
Diclofenac 5 marasmius androsaceus 0.75 spaleston 0.2
Gavirin tablet 0.04 Flos Carthami 6 Sanguis Draxonis 6
Radix Clematidis 4 Herba Lycopodiis 4 system Squama Manis 9
Sanguis Draxonis in the medicine of the present invention, Squama Manis, Flos Carthami blood circulation promoting and blood stasis dispelling, warming the meridian are monarch drug; The Herba Lycopodii removing obstruction in the collateral to relieve pain is a ministerial drug with the effect that increases monarch drug; Assistant is total to the damp eliminating heresy with diclofenac, marasmius androsaceus, spaleston, and gavirin tablet can effectively be treated because the regurgitation phenomenon that other medicines may cause is messenger drug.Many medicines share, and the heresy of can drying, pain relieves the pain.
Medicine of the present invention can be made various dosage forms according to a conventional method.Wherein preferred capsule formulation.
Capsule preparation method thereof:
Squama Manis is pulverized with Herba Lycopodii, Flos Carthami, Sanguis Draxonis and Radix Clematidis according to the method for the scalding process of preparing Chinese medicine, dry back; With diclofenac, marasmius androsaceus, spaleston and gavirin tablet with after above-mentioned fine powder mixes, packing.
For showing that medicine of the present invention is to rheumatism and treatment of rheumatoid arthritis effect, the rheumatism and the rheumatoid arthritis case of all ages and classes, sex and the different courses of disease have systematically been selected, symptom is pain numbness, ankylosis and in various degree trick and joint deformity, erythrocyte sedimentation rate is generally per hour 20-25, reaches as high as per hour 28-30 during morbidity.Use medicine of the present invention to treat, be 30 days a course of treatment.
Instructions of taking: every day 2-3 time, a 2-4 grain, every 0.3 gram.Its therapeutic effect can be referring to table 1 and table 2 clinical data statistics.Treatment cycle is 4-5 the course of treatment.
Produce effects: symptom all disappears, and the erythrocyte sedimentation rate value reaches normal value, is 0-20 per hour;
Effectively: the state of an illness is eased, and pain disappears, and lives through ruton, and the erythrocyte sedimentation rate value is 0-23 per hour;
Invalid: symptom and erythrocyte sedimentation rate value do not have obvious improvement.
The different course of disease clinical data statistics of table 1
| The course of disease (year) | Case load (people) | Produce effects | Effectively | Invalid |
| ????1-2 | ????18 | ????14 | ????4 | ????0 |
| ????2-5 | ????43 | ????24 | ????17 | ????2 |
| ????5-10 | ????39 | ????18 | ????20 | ????1 |
| Effective percentage 56% 41% 3% | ||||
Table 2 all ages and classes clinical data statistics
| Age (year) | Case load (people) | Produce effects | Effectively | Invalid |
| ??13-20 | ????16 | ????12 | ????4 | ????0 |
| ??21-45 | ????33 | ????13 | ????19 | ????1 |
| ??50-67 | ????51 | ????31 | ????18 | ????2 |
| Effective percentage 56% 41% 3% | ||||
By above-mentioned clinical data as seen, the symptom of rheumatism and rheumatoid arthritis can be eliminated and alleviate to medicine treating both the principal and secondary aspects of a disease of the present invention quickly, and the pain phenomenon is disappeared, and dredge the meridian passage makes that erythrocyte sedimentation rate numerical value is most of to recover normal.Therapeutic effect has stability, certainty.Taking convenience, patient easily accepts, and side effect is little, and expense is low.
Embodiment
Take by weighing raw material (kilogram) by following proportioning:
Diclofenac 5 marasmius androsaceus 0.75 spaleston 0.2
Gavirin tablet 0.04 Flos Carthami 6 Sanguis Draxonis 6
Radix Clematidis 4 Herba Lycopodiis 4 system Squama Manis 9
Capsule preparation method thereof:
With Squama Manis size separately, according to the method for scalding (" in 1995 version appendix of Chinese pharmacopoeia IID) with stir-baking in sand to heaving, pulverize with Herba Lycopodii, Flos Carthami, Sanguis Draxonis and Radix Clematidis after the clean dry; With after above-mentioned fine powder mixes, packing is adorned 0.3 gram for every with diclofenac, marasmius androsaceus, spaleston and gavirin tablet fine powder.Model case:
1. Li Dian respects, man, 68 years old, Yang Ming people from village, town, the old Black Hills of Heilongjiang Province's DongNing.Played trouble rheumatic arthritis in 1976, disease is seen symptoms such as lumbago, skelalgia, muscle spasm, takes several Chinese medicine and western medicine, and effect is all undesirable.Take medicine of the present invention and promptly fully recover after three courses of treatment, symptom all disappears and erythrocyte sedimentation rate recovers normal.
2. open little brightness, woman, 42 years old, Boshan District, Zibo City, Shandong Province Cortex Populi dividianae river power plant worker.In year surplus the trouble rheumatoid arthritis 20, symptom is a pain numbness, deformation of hands and feet, ankylosis.Through taking medicine of the present invention 1 year, pain disappears, and the trick activity is normal, the work that can do housework, and erythrocyte sedimentation rate is reduced to per hour 19-23 from 28-30 per hour.
Claims (6)
1. medicine for the treatment of rheumatism and rheumatoid arthritis is characterized in that it is the medicament of being made by the following weight proportion raw material:
Diclofenac 3-10 marasmius androsaceus 0.5-1 spaleston 0.15-0.4
Gavirin tablet 0.03-0.07 Flos Carthami 4-8 Sanguis Draxonis 5-10
Radix Clematidis 3-8 Herba Lycopodii 3-7 system Squama Manis 7-15
2. the medicine of treatment rheumatism according to claim 1 and rheumatoid arthritis, wherein the weight proportion of each raw material is:
Diclofenac 5 marasmius androsaceus 0.75 spaleston 0.2
Gavirin tablet 0.04 Flos Carthami 6 Sanguis Draxonis 6
Radix Clematidis 4 Herba Lycopodiis 4 system Squama Manis 9
3. the medicine of treatment rheumatism according to claim 1 and 2 and rheumatoid arthritis is characterized in that said medicament is a said dosage form on any pharmaceutics.
4. the medicine of treatment rheumatism according to claim 3 and rheumatoid arthritis is characterized in that said medicament is a capsule.
5. according to the preparation method of said treatment rheumatism of claim 4 and medicine for treating rheumatoid arthritis, it is characterized in that: Squama Manis is pulverized with Herba Lycopodii, Flos Carthami, Sanguis Draxonis and Radix Clematidis according to the method for the scalding process of preparing Chinese medicine, dry back; With diclofenac, marasmius androsaceus, spaleston and gavirin tablet with after above-mentioned fine powder mixes, packing.
6. the preparation method of the medicine of treatment rheumatism according to claim 5 and rheumatoid arthritis, the weight that it is characterized in that said capsule are 0.3 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 98120481 CN1252289A (en) | 1998-10-26 | 1998-10-26 | Medicine for rheumarthritis and rheumatoid arthritis and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 98120481 CN1252289A (en) | 1998-10-26 | 1998-10-26 | Medicine for rheumarthritis and rheumatoid arthritis and its preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1252289A true CN1252289A (en) | 2000-05-10 |
Family
ID=5226763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 98120481 Pending CN1252289A (en) | 1998-10-26 | 1998-10-26 | Medicine for rheumarthritis and rheumatoid arthritis and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1252289A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003059370A1 (en) * | 2002-01-18 | 2003-07-24 | Pangenomics Co., Ltd. | Crude drug compositions for treating or preventing arthritic diseases and the preparation process |
| CN106177241A (en) * | 2016-08-22 | 2016-12-07 | 刘秋云 | A kind of Chinese medicine and western medicine compound preparation treating rheumatoid arthritis and preparation method |
-
1998
- 1998-10-26 CN CN 98120481 patent/CN1252289A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003059370A1 (en) * | 2002-01-18 | 2003-07-24 | Pangenomics Co., Ltd. | Crude drug compositions for treating or preventing arthritic diseases and the preparation process |
| CN106177241A (en) * | 2016-08-22 | 2016-12-07 | 刘秋云 | A kind of Chinese medicine and western medicine compound preparation treating rheumatoid arthritis and preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1839941A (en) | Chinese prepared medicine for treating bone pain | |
| CN100394955C (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
| CN103055260A (en) | Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof | |
| CN102309723A (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof | |
| CN106728615A (en) | Chinese medicine composition for synthetism life bone and preparation method thereof | |
| CN103565969A (en) | Traditional Chinese medicine composition for treating soft tissue injury and fracture | |
| CN116236550A (en) | Light traditional Chinese medicine formula preparation for treating novel coronavirus infection and preparation method thereof | |
| CN1294930C (en) | Medication for treating cough caused by inflammation of upper respiratory tract | |
| CN1252289A (en) | Medicine for rheumarthritis and rheumatoid arthritis and its preparation | |
| CN102145099A (en) | Traditional Chinese medicine for treating infertility caused by liver stagnation | |
| CN104547591A (en) | Pharmaceutical composition for treating acute ankle sprain | |
| CN1054052C (en) | Comedo-elimination preparation | |
| CN1259079C (en) | Osteopathy treating ointment | |
| CN1840146A (en) | Medicament for treating vitiligo | |
| CN1072500C (en) | Medical capsules for treating arthritides and its preparing process | |
| CN100509052C (en) | Traditional Chinese medicine preparation for treating bone spinal cord inflammation | |
| CN100335082C (en) | Medicine for treating rheumarthritis | |
| CN1899564A (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc | |
| CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
| CN1209130C (en) | Medicament for treating femoral head necrosis | |
| CN1172709C (en) | Medicine for treating rheumatalgia | |
| CN118021880A (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
| CN1175852C (en) | Medicine for treating hyperosteogeny | |
| CN1136890C (en) | Niantongbao capsule and its preparing process | |
| CN100496574C (en) | An externally applied Chinese herbal composition for treating scapulohumeral periarthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |